Entheon Biomedical Corp. reported earnings results for the third quarter and nine months ended August 31, 2023. For the third quarter, the company reported net loss was CAD 0.094856 million compared to net income of CAD 0.458193 million a year ago.
For the nine months, revenue was CAD 0.250323 million compared to CAD 0.069677 million a year ago. Net loss was CAD 0.226437 million compared to CAD 2.68 million a year ago.